Literature DB >> 19500902

Peroxiredoxins, a novel target in cancer radiotherapy.

Bo Zhang1, Yan Wang, Yongping Su.   

Abstract

Reactive oxygen species (ROS) are toxic at high levels in the mammalian cells. Mammalian cells have developed many enzymatic and nonenzymatic antioxidative systems in various cellular compartments to maintain an appropriate level of ROS and regulate their action. Peroxiredoxins (Prxs), a family of peroxidase that reduced intracellular peroxides (one type of ROS) with the thioredoxin system as the electron donor, were highly expressed in various cellular compartments. In this minireview, we discussed the regulation of Prxs expression in cancer cell and its relationship with ionizing radiation. As Prxs could be induced by radiation and its expression status could determine the radiosensitivity of cancer cells, Prxs might be a potential target for radiotherapy in cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500902     DOI: 10.1016/j.canlet.2009.04.043

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  49 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

2.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

Review 3.  Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.

Authors:  Jan F Stevens; Johana S Revel; Claudia S Maier
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

Review 4.  Overview of peroxiredoxins in oxidant defense and redox regulation.

Authors:  Leslie B Poole; Andrea Hall; Kimberly J Nelson
Journal:  Curr Protoc Toxicol       Date:  2011-08

5.  Kinetic and thermodynamic features reveal that Escherichia coli BCP is an unusually versatile peroxiredoxin.

Authors:  Stacy A Reeves; Derek Parsonage; Kimberly J Nelson; Leslie B Poole
Journal:  Biochemistry       Date:  2011-09-21       Impact factor: 3.162

6.  Comparative label-free LC-MS/MS analysis of colorectal adenocarcinoma and metastatic cells treated with 5-fluorouracil.

Authors:  Kerry M Bauer; Paul A Lambert; Amanda B Hummon
Journal:  Proteomics       Date:  2012-06       Impact factor: 3.984

7.  Comparative study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's disease.

Authors:  Hong Gao; Xiaomei Liu; Dong Chen; Liangying Lv; Mei Wu; Jie Mi; Weilin Wang
Journal:  Int J Exp Pathol       Date:  2014-04-29       Impact factor: 1.925

8.  8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.

Authors:  Ylermi Soini; Kirsi-Maria Haapasaari; Markku H Vaarala; Taina Turpeenniemi-Hujanen; V Kärjä; Peeter Karihtala
Journal:  Int J Clin Exp Pathol       Date:  2011-03-02

9.  Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer.

Authors:  Bo Zhang; Kai Wang; Gang He; Xinying Guan; Botao Liu; Yangbo Liu; Yun Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

10.  Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell.

Authors:  Da-Jian Zhu; Xiao-Wu Chen; Jia-Zhi Wang; Yong-Le Ju; Man-Zhao Ou Yang; Wei-Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.